0001181431-13-013837.txt : 20130304
0001181431-13-013837.hdr.sgml : 20130304
20130304130718
ACCESSION NUMBER: 0001181431-13-013837
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130301
FILED AS OF DATE: 20130304
DATE AS OF CHANGE: 20130304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 28TH STREET
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 2525 28TH STREET
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAST ERLE T
CENTRAL INDEX KEY: 0001051411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 13660782
MAIL ADDRESS:
STREET 1: C/O SPIROS DEVELOPMENT CORP II INC
STREET 2: 7475 LUSK BLVD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
rrd372560.xml
FORM 4
X0306
4
2013-03-01
0
0001466301
Clovis Oncology, Inc.
CLVS
0001051411
MAST ERLE T
C/O CLOVIS ONCOLOGY, INC.
2525 28TH STREET, SUITE 100
BOULDER
CO
80301
0
1
0
0
Executive VP and CFO
Stock Option (right to buy)
21.81
2013-03-01
4
A
0
75000
0
A
2023-03-01
Common Stock
75000
75000
D
The option shall vest as to 25% of the shares on March 1, 2014 and the remainder shall vest in substantially equal installments over the 36 months immediately following such date.
/s/ Erle T. Mast
2013-03-01